Morgan Stanley (MS-PQ) Research & Development (2009 - 2026)

Morgan Stanley (MS-PQ) has 18 years of Research & Development data on file, last reported at $1.1 billion in Q1 2026.

• Quarterly Research & Development rose 9.33% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 8.51% YoY) and the FY2025 annual result came in at $4.4 billion, up 8.07% from the prior year.
• Research & Development fell to $1.1 billion in Q1 2026 per MS-PQ's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Research & Development topped out at $1.2 billion in Q4 2025 and bottomed at $829.0 million in Q1 2022.
• The 5-year median for Research & Development is $987.0 million (2023), against an average of $995.4 million.
• The widest annual swing landed in 2022, when Research & Development grew 13.1%; it then climbed 5.79% in 2023.
• Tracing MS-PQ's Research & Development over 5 years: stood at $933.0 million in 2022, then grew by 5.79% to $987.0 million in 2023, then increased by 7.29% to $1.1 billion in 2024, then rose by 9.54% to $1.2 billion in 2025, then declined by 1.03% to $1.1 billion in 2026.
• Per Business Quant, the three latest MS-PQ Research & Development figures stand at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.1 billion (Q3 2025).

Peer Comparison